« Previous
Next »
American Journal of Ophthalmology
Volume 133, Issue 2
, Pages 211-214
, February 2002
Verteporfin infusion-associated pain
References
- . Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Arch Ophthalmol. 1999;117:1329–1345
-
Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York: John Wiley and Sons; 1981;56–61.
-
Miller JW, Walsh AW, Kramer M, et al. Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin. Arch Ophthalmol 1995;113:810–808.
- . Evidence for low-density lipoprotein receptor-mediated uptake of benzoporphyrin derivative. Br J Cancer. 1994;69:833–839
-
Kramer M, Miller JW, Michaud N, et al. Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: selective treatment of choroidal neovascularization in monkeys. Ophthalmology 1996 Mar;103:427–438.
- Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration (results of a single treatment in a phase 1 and 2 study). Arch Ophthalmol. 1999;117:1161–1173
- Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration (results of retreatments in a phase 1 and 2 study). Arch Ophthalmol. 1999;117:1177–1187
-
.
Chest and back pain associated with a six-hour infusion of liposomal daunorubicin.
Ann Pharmacol. 2000;34:810–811
-
.
Chest discomfort associated with liposomal amphotericin B (report of three cases and review of the literature).
Pharmacother. 1998;18:1053–1061
- . Pulmonary intravascular macrophages and hemodynamic effects of liposomes in sheep. J Appl Physiol. 1988;64:1143–1152
☆ Supported by The Macula Foundation, Inc. The authors have no financial interest in any aspect of this study.
PII: S0002-9394(01)01341-1
© 2002 Elsevier Science Inc. All rights reserved.
« Previous
Next »
American Journal of Ophthalmology
Volume 133, Issue 2
, Pages 211-214
, February 2002
